(554976, 'HP:0031925', 'Rosette', 'MP:0013702', 'abnormal megakaryocyte-erythroid progenitor cell morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(554977, 'HP:0031925', 'Rosette', 'MP:0030951', 'abnormal endocytosis', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(554978, 'HP:0031925', 'Rosette', 'MP:0004150', 'absent caveolae', 0.5, 6.121988824155609, 1.7495697791393758, 'UPHENO:0084928', 'abnormal cell morphology'),
(554979, 'HP:0031925', 'Rosette', 'MP:0031310', 'abnormal cyst', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(554980, 'HP:0031925', 'Rosette', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(554981, 'HP:0031925', 'Rosette', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(554982, 'HP:0031925', 'Rosette', 'MP:0030579', 'thoracoabdominoschisis', 0.4074074074074074, 2.6504988612427964, 1.039150070680464, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(554983, 'HP:0031925', 'Rosette', 'MP:0003674', 'oxidative stress', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(554984, 'HP:0031925', 'Rosette', 'MP:0002182', 'abnormal astrocyte morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(554985, 'HP:0031925', 'Rosette', 'MP:0003877', 'abnormal serotonergic neuron morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(554986, 'HP:0031925', 'Rosette', 'MP:0003199', 'calcified muscle', 0.42857142857142855, 3.008048030199787, 1.1354133350961642, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(554987, 'HP:0031925', 'Rosette', 'MP:0013176', 'abnormal tail position or orientation', 0.4074074074074074, 2.6504988612427964, 1.039150070680464, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(554988, 'HP:0031925', 'Rosette', 'MP:0013315', 'abnormal pheomelanosome morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(554989, 'HP:0031925', 'Rosette', 'MP:0030954', 'abnormal Golgi cis cisterna morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(554990, 'HP:0031925', 'Rosette', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(554991, 'HP:0031925', 'Rosette', 'MP:0000462', 'abnormal digestive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(554992, 'HP:0031925', 'Rosette', 'MP:0014134', 'abnormal embryo morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(554993, 'HP:0031925', 'Rosette', 'MP:0003630', 'abnormal urothelium morphology', 0.4230769230769231, 2.6504988612427964, 1.0589451840551005, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(554994, 'HP:0031925', 'Rosette', 'MP:0003927', 'increased cellular glucose import', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(554995, 'HP:0031925', 'Rosette', 'MP:0001585', 'hemolytic anemia', 0.41379310344827586, 4.8755453832354885, 1.420375673944019, 'UPHENO:0086172', 'abnormal cell'),
(554996, 'HP:0031925', 'Rosette', 'MP:0003245', 'abnormal GABAergic neuron morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(554997, 'HP:0031925', 'Rosette', 'MP:0002655', 'abnormal keratinocyte morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(554998, 'HP:0031925', 'Rosette', 'MP:0005623', 'abnormal meninges morphology', 0.4230769230769231, 2.6504988612427964, 1.0589451840551005, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(554999, 'HP:0031925', 'Rosette', 'MP:0004023', 'abnormal chromosome number', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555000, 'HP:0031925', 'Rosette', 'MP:0008196', 'abnormal follicular dendritic cell morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(555001, 'HP:0031925', 'Rosette', 'MP:0004141', 'abnormal enteroendocrine cell morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(555002, 'HP:0031925', 'Rosette', 'MP:0004808', 'abnormal hematopoietic stem cell morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(555003, 'HP:0031925', 'Rosette', 'MP:0002810', 'microcytic anemia', 0.41379310344827586, 4.8755453832354885, 1.420375673944019, 'UPHENO:0086172', 'abnormal cell'),
(555004, 'HP:0031925', 'Rosette', 'MP:0003719', 'abnormal pericyte morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555005, 'HP:0031925', 'Rosette', 'MP:0001038', 'abnormal cholinergic neuron morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555006, 'HP:0031925', 'Rosette', 'MP:0008415', 'abnormal neurite morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555007, 'HP:0031925', 'Rosette', 'MP:0004090', 'abnormal sarcomere morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(555008, 'HP:0031925', 'Rosette', 'MP:0002882', 'abnormal neuron morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(555009, 'HP:0031925', 'Rosette', 'MP:0011637', 'abnormal mitochondrial matrix morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(555010, 'HP:0031925', 'Rosette', 'MP:0003201', 'extremity edema', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555011, 'HP:0031925', 'Rosette', 'MP:0002111', 'abnormal tail morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555012, 'HP:0031925', 'Rosette', 'MP:0000749', 'muscle degeneration', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555013, 'HP:0031925', 'Rosette', 'MP:0000316', 'cellular necrosis', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555014, 'HP:0031925', 'Rosette', 'MP:0006361', 'abnormal female germ cell morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555015, 'HP:0031925', 'Rosette', 'MP:0014238', 'abnormal ribosome morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(555016, 'HP:0031925', 'Rosette', 'MP:0003077', 'abnormal cell cycle', 0.4230769230769231, 4.8755453832354885, 1.4362209924176599, 'UPHENO:0086172', 'abnormal cell'),
(555017, 'HP:0031925', 'Rosette', 'MP:0003091', 'abnormal cell migration', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555018, 'HP:0031925', 'Rosette', 'MP:0008890', 'abnormal nuclear lamina morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555019, 'HP:0031925', 'Rosette', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555020, 'HP:0031925', 'Rosette', 'MP:0009117', 'abnormal white fat cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555021, 'HP:0031925', 'Rosette', 'MP:0013656', 'abnormal hematopoietic cell morphology', 0.5, 6.121988824155609, 1.7495697791393758, 'UPHENO:0084928', 'abnormal cell morphology'),
(555022, 'HP:0031925', 'Rosette', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555023, 'HP:0031925', 'Rosette', 'MP:0013658', 'abnormal myeloid cell morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(555024, 'HP:0031925', 'Rosette', 'MP:0003243', 'abnormal dopaminergic neuron morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555025, 'HP:0031925', 'Rosette', 'MP:0030953', 'abnormal Golgi cisterna morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555026, 'HP:0031925', 'Rosette', 'MP:0008753', 'abnormal osteocyte morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555027, 'HP:0031925', 'Rosette', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555028, 'HP:0031925', 'Rosette', 'MP:0002183', 'gliosis', 0.42857142857142855, 4.8755453832354885, 1.445517018218072, 'UPHENO:0086172', 'abnormal cell'),
(555029, 'HP:0031925', 'Rosette', 'MP:0002811', 'macrocytic anemia', 0.41379310344827586, 4.8755453832354885, 1.420375673944019, 'UPHENO:0086172', 'abnormal cell'),
(555030, 'HP:0031925', 'Rosette', 'MP:0030567', 'abnormal I band morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555031, 'HP:0031925', 'Rosette', 'MP:0009116', 'abnormal brown fat cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555032, 'HP:0031925', 'Rosette', 'MP:0013314', 'abnormal eumelanosome morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555033, 'HP:0031925', 'Rosette', 'MP:0002229', 'neurodegeneration', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555034, 'HP:0031925', 'Rosette', 'MP:0012021', 'abnormal melanocyte number', 0.5384615384615384, 6.121988824155609, 1.8156143645331664, 'UPHENO:0084928', 'abnormal cell morphology'),
(555035, 'HP:0031925', 'Rosette', 'MP:0002429', 'abnormal blood cell morphology/development', 0.4444444444444444, 4.8755453832354885, 1.4720424787402613, 'UPHENO:0086172', 'abnormal cell'),
(555036, 'HP:0031925', 'Rosette', 'MP:0020851', 'abnormal vacuole morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(555037, 'HP:0031925', 'Rosette', 'MP:0009115', 'abnormal fat cell morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(555038, 'HP:0031925', 'Rosette', 'MP:0003634', 'abnormal glial cell morphology', 0.4444444444444444, 4.8755453832354885, 1.4720424787402613, 'UPHENO:0086172', 'abnormal cell'),
(555039, 'HP:0031925', 'Rosette', 'MP:0013205', 'abnormal nonmotile primary cilium morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555040, 'HP:0031925', 'Rosette', 'MP:0012360', 'abnormal large unstained cell number', 0.5, 6.121988824155609, 1.7495697791393758, 'UPHENO:0084928', 'abnormal cell morphology'),
(555041, 'HP:0031925', 'Rosette', 'MP:0020846', 'abnormal cell motility', 0.4230769230769231, 4.8755453832354885, 1.4362209924176599, 'UPHENO:0086172', 'abnormal cell'),
(555042, 'HP:0031925', 'Rosette', 'MP:0006322', 'abnormal perichondrium morphology', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555043, 'HP:0031925', 'Rosette', 'MP:0005621', 'abnormal cell physiology', 0.44, 4.8755453832354885, 1.4646637732338486, 'UPHENO:0086172', 'abnormal cell'),
(555044, 'HP:0031925', 'Rosette', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4230769230769231, 4.8755453832354885, 1.4362209924176599, 'UPHENO:0086172', 'abnormal cell'),
(555045, 'HP:0031925', 'Rosette', 'MP:0008887', 'abnormal splicing factor domain morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555046, 'HP:0031925', 'Rosette', 'MP:0011975', 'neuronal cytoplasmic inclusions', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(555047, 'HP:0031925', 'Rosette', 'MP:0000358', 'abnormal cell morphology', 0.6363636363636364, 6.121988824155609, 1.9737809072734505, 'UPHENO:0084928', 'abnormal cell morphology'),
(555048, 'HP:0031925', 'Rosette', 'MP:0003279', 'aneurysm', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555049, 'HP:0031925', 'Rosette', 'MP:0030913', 'abnormal melanosome formation', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555050, 'HP:0031925', 'Rosette', 'MP:0002883', 'chromatolysis', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(555051, 'HP:0031925', 'Rosette', 'MP:0013328', 'visceromegaly', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555052, 'HP:0031925', 'Rosette', 'MP:0030566', 'abnormal A band morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555053, 'HP:0031925', 'Rosette', 'MP:0012203', 'abnormal neuronal stem cell morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(555054, 'HP:0031925', 'Rosette', 'MP:0008830', 'abnormal nucleolus morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555055, 'HP:0031925', 'Rosette', 'MP:0003084', 'abnormal skeletal muscle fiber morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555056, 'HP:0031925', 'Rosette', 'MP:0009587', 'abnormal plasma membrane sphingolipid content', 0.5, 6.121988824155609, 1.7495697791393758, 'UPHENO:0084928', 'abnormal cell morphology'),
(555057, 'HP:0031925', 'Rosette', 'MP:0011743', 'abnormal Golgi apparatus morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(555058, 'HP:0031925', 'Rosette', 'MP:0008923', 'thoracoschisis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555059, 'HP:0031925', 'Rosette', 'MP:0008886', 'abnormal PML bodies', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555060, 'HP:0031925', 'Rosette', 'MP:0009840', 'abnormal foam cell morphology', 0.5833333333333334, 6.121988824155609, 1.8897513453955008, 'UPHENO:0084928', 'abnormal cell morphology'),
(555061, 'HP:0031925', 'Rosette', 'MP:0020850', 'abnormal microtubule cytoskeleton morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555062, 'HP:0031925', 'Rosette', 'MP:0008942', 'abnormal induced cell death', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555063, 'HP:0031925', 'Rosette', 'MP:0003903', 'increased cell mass', 0.5, 6.121988824155609, 1.7495697791393758, 'UPHENO:0084928', 'abnormal cell morphology'),
(555064, 'HP:0031925', 'Rosette', 'MP:0002877', 'abnormal melanocyte morphology', 0.56, 6.121988824155609, 1.851570614782796, 'UPHENO:0084928', 'abnormal cell morphology'),
(555065, 'HP:0031925', 'Rosette', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555066, 'HP:0031925', 'Rosette', 'MP:0003956', 'abnormal body size', 0.46153846153846156, 3.008048030199787, 1.178274102275107, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555067, 'HP:0031925', 'Rosette', 'MP:0004661', 'absent thyroid parafollicular C-cells', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555068, 'HP:0031925', 'Rosette', 'MP:0003385', 'abnormal body wall morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555069, 'HP:0031925', 'Rosette', 'MP:0005508', 'abnormal skeleton morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555070, 'HP:0031925', 'Rosette', 'MP:0013332', 'peliosis', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555071, 'HP:0031925', 'Rosette', 'MP:0004986', 'abnormal osteoblast morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555072, 'HP:0031925', 'Rosette', 'MP:0002163', 'abnormal gland morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555073, 'HP:0031925', 'Rosette', 'MP:0006281', 'abnormal tail development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555074, 'HP:0031925', 'Rosette', 'MP:0012556', 'increased cell death', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555075, 'HP:0031925', 'Rosette', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4230769230769231, 4.8755453832354885, 1.4362209924176599, 'UPHENO:0086172', 'abnormal cell'),
(555076, 'HP:0031925', 'Rosette', 'MP:0006380', 'abnormal spermatid morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555077, 'HP:0031925', 'Rosette', 'MP:0010385', 'abnormal glycinergic neuron morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555078, 'HP:0031925', 'Rosette', 'MP:0000428', 'abnormal craniofacial morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555079, 'HP:0031925', 'Rosette', 'MP:0002108', 'abnormal muscle morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555080, 'HP:0031925', 'Rosette', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555081, 'HP:0031925', 'Rosette', 'MP:0002400', 'abnormal multipotent stem cell morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(555082, 'HP:0031925', 'Rosette', 'MP:0003247', 'abnormal glutaminergic neuron morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555083, 'HP:0031925', 'Rosette', 'MP:0020849', 'abnormal actin cytoskeleton morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555084, 'HP:0031925', 'Rosette', 'MP:0005500', 'abnormal gustatory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555085, 'HP:0031925', 'Rosette', 'MP:0020982', 'abnormal skin adnexa development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555086, 'HP:0031925', 'Rosette', 'MP:0011634', 'abnormal mitochondrial inner membrane morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555087, 'HP:0031925', 'Rosette', 'MP:0002132', 'abnormal respiratory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555088, 'HP:0031925', 'Rosette', 'MP:0005076', 'abnormal cell differentiation', 0.4230769230769231, 4.8755453832354885, 1.4362209924176599, 'UPHENO:0086172', 'abnormal cell'),
(555089, 'HP:0031925', 'Rosette', 'MP:0008387', 'hypochromic anemia', 0.41379310344827586, 4.8755453832354885, 1.420375673944019, 'UPHENO:0086172', 'abnormal cell'),
(555090, 'HP:0031925', 'Rosette', 'MP:0020581', 'abnormal neuron polarity', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(555091, 'HP:0031925', 'Rosette', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555092, 'HP:0031925', 'Rosette', 'MP:0005499', 'abnormal olfactory system morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555093, 'HP:0031925', 'Rosette', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555094, 'HP:0031925', 'Rosette', 'MP:0008946', 'abnormal neuron number', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555095, 'HP:0031925', 'Rosette', 'MP:0004698', 'abnormal thyroid parafollicular C-cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555096, 'HP:0031925', 'Rosette', 'MP:0002925', 'abnormal cardiovascular development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555097, 'HP:0031925', 'Rosette', 'MP:0004134', 'abnormal chest morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555098, 'HP:0031925', 'Rosette', 'MP:0003258', 'hiatal hernia', 0.4074074074074074, 2.6504988612427964, 1.039150070680464, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555099, 'HP:0031925', 'Rosette', 'MP:0001124', 'abnormal gametes', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555100, 'HP:0031925', 'Rosette', 'MP:0014010', 'abnormal peroxisome morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(555101, 'HP:0031925', 'Rosette', 'MP:0013657', 'abnormal blood cell morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(555102, 'HP:0031925', 'Rosette', 'MP:0030908', 'abnormal melanocyte differentiation', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555103, 'HP:0031925', 'Rosette', 'MP:0004046', 'abnormal mitosis', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555104, 'HP:0031925', 'Rosette', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555105, 'HP:0031925', 'Rosette', 'MP:0002582', 'disorganized extraembryonic tissue', 0.4444444444444444, 3.008048030199787, 1.1562483451423184, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555106, 'HP:0031925', 'Rosette', 'MP:0004087', 'abnormal muscle fiber morphology', 0.5, 6.121988824155609, 1.7495697791393758, 'UPHENO:0084928', 'abnormal cell morphology'),
(555107, 'HP:0031925', 'Rosette', 'MP:0000013', 'abnormal adipose tissue distribution', 0.42857142857142855, 3.008048030199787, 1.1354133350961642, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555108, 'HP:0031925', 'Rosette', 'MP:0012022', 'increased melanocyte number', 0.5185185185185185, 6.121988824155609, 1.7816746547807467, 'UPHENO:0084928', 'abnormal cell morphology'),
(555109, 'HP:0031925', 'Rosette', 'MP:0006035', 'abnormal mitochondrial morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(555110, 'HP:0031925', 'Rosette', 'MP:0005075', 'abnormal melanosome morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555111, 'HP:0031925', 'Rosette', 'MP:0011633', 'abnormal mitochondrial shape', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555112, 'HP:0031925', 'Rosette', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4230769230769231, 4.8755453832354885, 1.4362209924176599, 'UPHENO:0086172', 'abnormal cell'),
(555113, 'HP:0031925', 'Rosette', 'MP:0003449', 'abnormal intestinal goblet cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555114, 'HP:0031925', 'Rosette', 'MP:0000685', 'abnormal immune system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555115, 'HP:0031925', 'Rosette', 'MP:0004101', 'abnormal brain interneuron morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555116, 'HP:0031925', 'Rosette', 'MP:0020378', 'abnormal cell cytoskeleton morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(555117, 'HP:0031925', 'Rosette', 'MP:0002208', 'abnormal germ cell morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(555118, 'HP:0031925', 'Rosette', 'MP:0012555', 'decreased cell death', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555119, 'HP:0031925', 'Rosette', 'MP:0011180', 'abnormal hematopoietic cell number', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(555120, 'HP:0031925', 'Rosette', 'MP:0000350', 'abnormal cell proliferation', 0.4230769230769231, 4.8755453832354885, 1.4362209924176599, 'UPHENO:0086172', 'abnormal cell'),
(555121, 'HP:0031925', 'Rosette', 'MP:0014239', 'abnormal intracellular organelle morphology', 0.5185185185185185, 6.121988824155609, 1.7816746547807467, 'UPHENO:0084928', 'abnormal cell morphology'),
(555122, 'HP:0031925', 'Rosette', 'MP:0011999', 'abnormal tail length', 0.42857142857142855, 3.008048030199787, 1.1354133350961642, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555123, 'HP:0031925', 'Rosette', 'MP:0003926', 'decreased cellular glucose uptake', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555124, 'HP:0031925', 'Rosette', 'MP:0006378', 'abnormal spermatogonia morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555125, 'HP:0031925', 'Rosette', 'MP:0001032', 'abnormal peptidergic neuron morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555126, 'HP:0031925', 'Rosette', 'MP:0005058', 'abnormal lysosome morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555127, 'HP:0031925', 'Rosette', 'MP:0011113', 'abnormal airway basal cell morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(555128, 'HP:0031925', 'Rosette', 'MP:0009538', 'abnormal synapse morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555129, 'HP:0031925', 'Rosette', 'MP:0020848', 'abnormal exocytosis', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555130, 'HP:0031925', 'Rosette', 'MP:0001259', 'abnormal body weight', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555131, 'HP:0031925', 'Rosette', 'MP:0030952', 'abnormal Golgi stack morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555132, 'HP:0031925', 'Rosette', 'MP:0008199', 'increased follicular dendritic cell number', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(555133, 'HP:0031925', 'Rosette', 'MP:0010381', 'abnormal dosage compensation', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555134, 'HP:0031925', 'Rosette', 'MP:0000166', 'abnormal chondrocyte morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(555135, 'HP:0031925', 'Rosette', 'MP:0013113', 'greasy tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555136, 'HP:0031925', 'Rosette', 'MP:0013118', 'swellings', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555137, 'HP:0031925', 'Rosette', 'MP:0013707', 'abnormal hematopoietic precursor cell morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(555138, 'HP:0031925', 'Rosette', 'MP:0006379', 'abnormal spermatocyte morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555139, 'HP:0031925', 'Rosette', 'MP:0010678', 'abnormal skin adnexa morphology', 0.43478260869565216, 2.6504988612427964, 1.0734946712657676, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555140, 'HP:0031925', 'Rosette', 'MP:0003950', 'abnormal plasma membrane morphology', 0.5185185185185185, 6.121988824155609, 1.7816746547807467, 'UPHENO:0084928', 'abnormal cell morphology'),
(555141, 'HP:0031925', 'Rosette', 'MP:0020973', 'abnormal gland development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555142, 'HP:0031925', 'Rosette', 'MP:0004233', 'abnormal muscle weight', 0.4074074074074074, 2.6504988612427964, 1.039150070680464, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555143, 'HP:0031925', 'Rosette', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555144, 'HP:0031925', 'Rosette', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555145, 'HP:0031925', 'Rosette', 'MP:0013258', 'abnormal extracellular matrix morphology', 0.44, 4.8755453832354885, 1.4646637732338486, 'UPHENO:0086172', 'abnormal cell'),
(555146, 'HP:0031925', 'Rosette', 'MP:0003186', 'abnormal redox activity', 0.4230769230769231, 4.8755453832354885, 1.4362209924176599, 'UPHENO:0086172', 'abnormal cell'),
(555147, 'HP:0031925', 'Rosette', 'MP:0001105', 'abnormal PNS glial cell morphology', 0.42857142857142855, 4.8755453832354885, 1.445517018218072, 'UPHENO:0086172', 'abnormal cell'),
(555148, 'HP:0031925', 'Rosette', 'MP:0000952', 'abnormal CNS glial cell morphology', 0.42857142857142855, 4.8755453832354885, 1.445517018218072, 'UPHENO:0086172', 'abnormal cell'),
(555149, 'HP:0031925', 'Rosette', 'MP:0009536', 'abnormal interstitial cell of Cajal morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(555150, 'HP:0031925', 'Rosette', 'MP:0003257', 'abnormal abdominal wall morphology', 0.4230769230769231, 2.6504988612427964, 1.0589451840551005, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555151, 'HP:0031925', 'Rosette', 'MP:0004272', 'abnormal basement membrane morphology', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555152, 'HP:0031925', 'Rosette', 'MP:0030955', 'abnormal Golgi trans cisterna morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555153, 'HP:0031925', 'Rosette', 'MP:0013203', 'abnormal primary cilium morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(555154, 'HP:0031925', 'Rosette', 'MP:0031094', 'organomegaly', 0.4444444444444444, 3.008048030199787, 1.1562483451423184, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555155, 'HP:0031925', 'Rosette', 'MP:0005406', 'abnormal heart size', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555156, 'HP:0031925', 'Rosette', 'MP:0010233', 'hairless tail', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555157, 'HP:0031925', 'Rosette', 'MP:0021020', 'neurite dystrophy', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555158, 'HP:0031925', 'Rosette', 'MP:0003988', 'disorganized embryonic tissue', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555159, 'HP:0031925', 'Rosette', 'MP:0013206', 'abnormal motile cilium morphology', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(555160, 'HP:0031925', 'Rosette', 'MP:0003052', 'omphalocele', 0.4074074074074074, 2.6504988612427964, 1.039150070680464, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555161, 'HP:0031925', 'Rosette', 'MP:0010037', 'ectopic melanocytes', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(555162, 'HP:0031925', 'Rosette', 'MP:0001577', 'anemia', 0.42857142857142855, 4.8755453832354885, 1.445517018218072, 'UPHENO:0086172', 'abnormal cell'),
(555163, 'HP:0031925', 'Rosette', 'MP:0002632', 'vestigial tail', 0.42857142857142855, 3.008048030199787, 1.1354133350961642, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555164, 'HP:0031925', 'Rosette', 'MP:0030942', 'abnormal microtubule organizing center morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555165, 'HP:0031925', 'Rosette', 'MP:0020325', 'abnormal beige fat cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555166, 'HP:0031925', 'Rosette', 'MP:0008889', 'abnormal Gem morphology', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(555167, 'HP:0031925', 'Rosette', 'MP:0000351', 'increased cell proliferation', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555168, 'HP:0031925', 'Rosette', 'MP:0003702', 'abnormal chromosome morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555169, 'HP:0031925', 'Rosette', 'MP:0001256', 'abnormal body length', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555170, 'HP:0031925', 'Rosette', 'MP:0003902', 'abnormal cell mass', 0.56, 6.121988824155609, 1.851570614782796, 'UPHENO:0084928', 'abnormal cell morphology'),
(555171, 'HP:0031925', 'Rosette', 'MP:0011004', 'abnormal epidermal stem cell morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555172, 'HP:0031925', 'Rosette', 'MP:0002109', 'abnormal limb morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555173, 'HP:0031925', 'Rosette', 'MP:0002160', 'abnormal reproductive system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555174, 'HP:0031925', 'Rosette', 'MP:0000716', 'abnormal immune system cell morphology', 0.5185185185185185, 6.121988824155609, 1.7816746547807467, 'UPHENO:0084928', 'abnormal cell morphology'),
(555175, 'HP:0031925', 'Rosette', 'MP:0009841', 'foam cell reticulosis', 0.5185185185185185, 6.121988824155609, 1.7816746547807467, 'UPHENO:0084928', 'abnormal cell morphology'),
(555176, 'HP:0031925', 'Rosette', 'MP:0006362', 'abnormal male germ cell morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555177, 'HP:0031925', 'Rosette', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(555178, 'HP:0031925', 'Rosette', 'MP:0013202', 'abnormal cilium morphology', 0.5, 6.121988824155609, 1.7495697791393758, 'UPHENO:0084928', 'abnormal cell morphology'),
(555179, 'HP:0031925', 'Rosette', 'MP:0000352', 'decreased cell proliferation', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555180, 'HP:0031925', 'Rosette', 'MP:0003141', 'cardiac fibrosis', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555181, 'HP:0031925', 'Rosette', 'MP:0030915', 'abnormal melanosome maturation', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(555182, 'HP:0031925', 'Rosette', 'MP:0001253', 'abnormal body height', 0.41379310344827586, 3.008048030199787, 1.1156655097912829, 'UPHENO:0020584', 'abnormal anatomical entity morphology'),
(555183, 'HP:0031925', 'Rosette', 'MP:0001026', 'abnormal adrenergic neuron morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555184, 'HP:0031925', 'Rosette', 'MP:0012736', 'abnormal polar body morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555185, 'HP:0031925', 'Rosette', 'MP:0009378', 'abnormal endoplasmic reticulum morphology', 0.4827586206896552, 6.121988824155609, 1.7191401573539156, 'UPHENO:0084928', 'abnormal cell morphology'),
(555186, 'HP:0031925', 'Rosette', 'MP:0000313', 'abnormal cell death', 0.4230769230769231, 4.8755453832354885, 1.4362209924176599, 'UPHENO:0086172', 'abnormal cell'),
(555187, 'HP:0031925', 'Rosette', 'MP:0013659', 'abnormal erythroid lineage cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(555188, 'HP:0031925', 'Rosette', 'MP:0003111', 'abnormal cell nucleus morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(555189, 'HP:0031925', 'Rosette', 'MP:0001648', 'abnormal apoptosis', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555190, 'HP:0031925', 'Rosette', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.4074074074074074, 4.8755453832354885, 1.4093733729147593, 'UPHENO:0086172', 'abnormal cell'),
(555191, 'HP:0031925', 'Rosette', 'MP:0003904', 'decreased cell mass', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(555192, 'HP:0031925', 'Rosette', 'MP:0020550', 'multinucleated giant male germ cells', 0.4375, 6.121988824155609, 1.6365726719483247, 'UPHENO:0084928', 'abnormal cell morphology'),
(555193, 'HP:0031925', 'Rosette', 'MP:0012023', 'decreased melanocyte number', 0.5185185185185185, 6.121988824155609, 1.7816746547807467, 'UPHENO:0084928', 'abnormal cell morphology'),
(555194, 'HP:0031925', 'Rosette', 'MP:0004191', 'neuronal intranuclear inclusions', 0.4666666666666667, 6.121988824155609, 1.6902449875504095, 'UPHENO:0084928', 'abnormal cell morphology'),
(555195, 'HP:0031925', 'Rosette', 'MP:0003566', 'abnormal cell adhesion', 0.4230769230769231, 4.8755453832354885, 1.4362209924176599, 'UPHENO:0086172', 'abnormal cell'),
(555196, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555197, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555198, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555199, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555200, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555201, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555202, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555203, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555204, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555205, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555206, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555207, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555208, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555209, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555210, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555211, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555212, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555213, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555214, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555215, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555216, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555217, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555218, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555219, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555220, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555221, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555222, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555223, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555224, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555225, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555226, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555227, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555228, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555229, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555230, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555231, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555232, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555233, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555234, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555235, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555236, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555237, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555238, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555239, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555240, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555241, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555242, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555243, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555244, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555245, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555246, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555247, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555248, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555249, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555250, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555251, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555252, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555253, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555254, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555255, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555256, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555257, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555258, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555259, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555260, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555261, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555262, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555263, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555264, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555265, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555266, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555267, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555268, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555269, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555270, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555271, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555272, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555273, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555274, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555275, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555276, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555277, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555278, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555279, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555280, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555281, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555282, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555283, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555284, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555285, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555286, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555287, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555288, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555289, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555290, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555291, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555292, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555293, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555294, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555295, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555296, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555297, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555298, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555299, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555300, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555301, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555302, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555303, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555304, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555305, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555306, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555307, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555308, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555309, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555310, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555311, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555312, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555313, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555314, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555315, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555316, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555317, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555318, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555319, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555320, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555321, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555322, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555323, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555324, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555325, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555326, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555327, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555328, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555329, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555330, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555331, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555332, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555333, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555334, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555335, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555336, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555337, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555338, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555339, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555340, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555341, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555342, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555343, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555344, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555345, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555346, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555347, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555348, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555349, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555350, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555351, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555352, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555353, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555354, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555355, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555356, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555357, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555358, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555359, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555360, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555361, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555362, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555363, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555364, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555365, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555366, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555367, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555368, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555369, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555370, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555371, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555372, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555373, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555374, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555375, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555376, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555377, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555378, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555379, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555380, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555381, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555382, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555383, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555384, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555385, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555386, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555387, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555388, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555389, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555390, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555391, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555392, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555393, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555394, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555395, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555396, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555397, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555398, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555399, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555400, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555401, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555402, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555403, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555404, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555405, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555406, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555407, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555408, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555409, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555410, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555411, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555412, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555413, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555414, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555415, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555416, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555417, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555418, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555419, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555420, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555421, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555422, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555423, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555424, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555425, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555426, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555427, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555428, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555429, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555430, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555431, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555432, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555433, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555434, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555435, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555436, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555437, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555438, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555439, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555440, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555441, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555442, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555443, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555444, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555445, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555446, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555447, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555448, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555449, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555450, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555451, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555452, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555453, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555454, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555455, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555456, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555457, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555458, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555459, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555460, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555461, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555462, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555463, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555464, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555465, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555466, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555467, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555468, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555469, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555470, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555471, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555472, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555473, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555474, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555475, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555476, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555477, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555478, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555479, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555480, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555481, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555482, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555483, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555484, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555485, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555486, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555487, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555488, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555489, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555490, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555491, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555492, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555493, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555494, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555495, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555496, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555497, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555498, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555499, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555500, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555501, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555502, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555503, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555504, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555505, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555506, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555507, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555508, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555509, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555510, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555511, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555512, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555513, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555514, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555515, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555516, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555517, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555518, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555519, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555520, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555521, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555522, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555523, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555524, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555525, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555526, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555527, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555528, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555529, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555530, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555531, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555532, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555533, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555534, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555535, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555536, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555537, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555538, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555539, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555540, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555541, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555542, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555543, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555544, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555545, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555546, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555547, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555548, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555549, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555550, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555551, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555552, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555553, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555554, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555555, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555556, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555557, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555558, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555559, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555560, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555561, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555562, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555563, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555564, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555565, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555566, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555567, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555568, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555569, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555570, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555571, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555572, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555573, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555574, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555575, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555576, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555577, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555578, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555579, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555580, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555581, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555582, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555583, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555584, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555585, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555586, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555587, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555588, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555589, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555590, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555591, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555592, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555593, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555594, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555595, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555596, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555597, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555598, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555599, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555600, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555601, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555602, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555603, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555604, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555605, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555606, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555607, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555608, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555609, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555610, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555611, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555612, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555613, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555614, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555615, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555616, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555617, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555618, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555619, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555620, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555621, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555622, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555623, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555624, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555625, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555626, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555627, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555628, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555629, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555630, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555631, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555632, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555633, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555634, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555635, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555636, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555637, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555638, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555639, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555640, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555641, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555642, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555643, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555644, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555645, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555646, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555647, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555648, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555649, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555650, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555651, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555652, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555653, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555654, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555655, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555656, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555657, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555658, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555659, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555660, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555661, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555662, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555663, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555664, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555665, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555666, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555667, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555668, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555669, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555670, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555671, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555672, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555673, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555674, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555675, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555676, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555677, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555678, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555679, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555680, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555681, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555682, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555683, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555684, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555685, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555686, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555687, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555688, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555689, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555690, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555691, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555692, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555693, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555694, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555695, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555696, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555697, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555698, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555699, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555700, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555701, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555702, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555703, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555704, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555705, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555706, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555707, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555708, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555709, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555710, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555711, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555712, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555713, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555714, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555715, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555716, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555717, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555718, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555719, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555720, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555721, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555722, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555723, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555724, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555725, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555726, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555727, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555728, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555729, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555730, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555731, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555732, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555733, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555734, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555735, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555736, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555737, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555738, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555739, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555740, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555741, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555742, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555743, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555744, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555745, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555746, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555747, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555748, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555749, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555750, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555751, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555752, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555753, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555754, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555755, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555756, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555757, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555758, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555759, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555760, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555761, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555762, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555763, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555764, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555765, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555766, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555767, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555768, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555769, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555770, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555771, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555772, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555773, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555774, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555775, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555776, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555777, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555778, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555779, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555780, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555781, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555782, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555783, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555784, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555785, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555786, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555787, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555788, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555789, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555790, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555791, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555792, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555793, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555794, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555795, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555796, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555797, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555798, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555799, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555800, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555801, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555802, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555803, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555804, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555805, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555806, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555807, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555808, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555809, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555810, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555811, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555812, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555813, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555814, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555815, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555816, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555817, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555818, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555819, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555820, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555821, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555822, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555823, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555824, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555825, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555826, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555827, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555828, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555829, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555830, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555831, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555832, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555833, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555834, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555835, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555836, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555837, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555838, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555839, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555840, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555841, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555842, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555843, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555844, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555845, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555846, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555847, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555848, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555849, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555850, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555851, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555852, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555853, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555854, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555855, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555856, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555857, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555858, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555859, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555860, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555861, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555862, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555863, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555864, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555865, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555866, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555867, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555868, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555869, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555870, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555871, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555872, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555873, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555874, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555875, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555876, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555877, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555878, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555879, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555880, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555881, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555882, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555883, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555884, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555885, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555886, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555887, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555888, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555889, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555890, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555891, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555892, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555893, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555894, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555895, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555896, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555897, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555898, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555899, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555900, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555901, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555902, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555903, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555904, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555905, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555906, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555907, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555908, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555909, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555910, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555911, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555912, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555913, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555914, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555915, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555916, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555917, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555918, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555919, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555920, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555921, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555922, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555923, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555924, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555925, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555926, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555927, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555928, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555929, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555930, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555931, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555932, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555933, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555934, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555935, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555936, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555937, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555938, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555939, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555940, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555941, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555942, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555943, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555944, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(555945, 'HP:0034079', 'Anti-centromere protein B antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(555946, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0005537', 'abnormal cerebral aqueduct morphology', 0.40540540540540543, 9.637520916954793, 1.976639338483663, 'UPHENO:0076795', 'abnormal midbrain morphology'),
(555947, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0004203', 'abnormal cranial flexure morphology', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(555948, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000841', 'abnormal hindbrain morphology', 0.4666666666666667, 6.213399309526074, 1.7028171788085475, 'UPHENO:0076805', 'abnormal brain morphology'),
(555949, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0009027', 'abnormal subarachnoid space morphology', 0.40625, 5.838687225017717, 1.5401190490229797, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(555950, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000906', 'abnormal trigeminal V mesencephalic nucleus morphology', 0.42857142857142855, 9.637520916954793, 2.0323302160983436, 'UPHENO:0076795', 'abnormal midbrain morphology'),
(555951, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000954', 'decreased oligodendrocyte progenitor number', 0.45161290322580644, 6.213399309526074, 1.675127249219083, 'UPHENO:0076805', 'abnormal brain morphology'),
(555952, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0008232', 'abnormal cingulum morphology', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(555953, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000783', 'abnormal forebrain morphology', 0.4666666666666667, 6.213399309526074, 1.7028171788085475, 'UPHENO:0076805', 'abnormal brain morphology'),
(555954, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0006291', 'aprosencephaly', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(555955, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0014065', 'Lewy bodies', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(555956, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0014063', 'Lafora bodies', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(555957, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0014067', 'Hirano bodies', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(555958, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0001890', 'anencephaly', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(555959, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0013564', 'abnormal sensory circumventricular organ morphology', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(555960, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0009022', 'abnormal brain meninges morphology', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(555961, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0002653', 'abnormal ependyma morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(555962, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000771', 'abnormal brain size', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(555963, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0020829', 'abnormal forebrain tissue architecture', 0.45161290322580644, 6.213399309526074, 1.675127249219083, 'UPHENO:0076805', 'abnormal brain morphology'),
(555964, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0003232', 'abnormal forebrain development', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(555965, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0009688', 'abnormal spinal cord central canal morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(555966, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0008503', 'abnormal spinal cord grey matter morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(555967, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000822', 'abnormal brain ventricle morphology', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(555968, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0021142', 'abnormal brain N-acetyl-L-aspartic acid level', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(555969, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0008026', 'abnormal brain white matter morphology', 0.4666666666666667, 6.213399309526074, 1.7028171788085475, 'UPHENO:0076805', 'abnormal brain morphology'),
(555970, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0014278', 'semilobar holoprosencephaly', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(555971, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000847', 'abnormal metencephalon morphology', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(555972, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0006100', 'abnormal tegmentum morphology', 0.45454545454545453, 9.637520916954793, 2.093010111272409, 'UPHENO:0076795', 'abnormal midbrain morphology'),
(555973, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0013562', 'abnormal circumventricular organ morphology', 0.4666666666666667, 6.213399309526074, 1.7028171788085475, 'UPHENO:0076805', 'abnormal brain morphology'),
(555974, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0005277', 'abnormal brainstem morphology', 0.4666666666666667, 6.213399309526074, 1.7028171788085475, 'UPHENO:0076805', 'abnormal brain morphology'),
(555975, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000849', 'abnormal cerebellum morphology', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(555976, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0005157', 'holoprosencephaly', 0.45161290322580644, 6.213399309526074, 1.675127249219083, 'UPHENO:0076805', 'abnormal brain morphology'),
(555977, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0020370', 'abnormal glymphatic system morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(555978, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0001891', 'hydrocephaly', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(555979, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0030014', 'calcified brain', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(555980, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0021002', 'brain lesion', 0.4827586206896552, 6.213399309526074, 1.7319272734329416, 'UPHENO:0076805', 'abnormal brain morphology'),
(555981, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000897', 'abnormal midbrain morphology', 0.4838709677419355, 9.637520916954793, 2.1594713641815355, 'UPHENO:0076795', 'abnormal midbrain morphology'),
(555982, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0006108', 'abnormal hindbrain development', 0.45161290322580644, 6.213399309526074, 1.675127249219083, 'UPHENO:0076805', 'abnormal brain morphology'),
(555983, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0003864', 'abnormal midbrain development', 0.45161290322580644, 6.213399309526074, 1.675127249219083, 'UPHENO:0076805', 'abnormal brain morphology'),
(555984, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000917', 'obstructive hydrocephaly', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(555985, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0003861', 'abnormal nervous system development', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(555986, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0009024', 'abnormal brain arachnoid mater morphology', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(555987, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0008540', 'abnormal cerebral hemisphere morphology', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(555988, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0012260', 'encephalomeningocele', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(555989, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0014064', 'argyrophilic inclusion bodies', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(555990, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0001893', 'non-obstructive hydrocephaly', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(555991, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0012132', 'abnormal midbrain-hindbrain boundary morphology', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(555992, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0012545', 'syringomyelia', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(555993, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0014062', 'nervous system inclusion bodies', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(555994, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0004250', 'tau protein deposits', 0.45161290322580644, 6.213399309526074, 1.675127249219083, 'UPHENO:0076805', 'abnormal brain morphology'),
(555995, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0009804', 'abnormal interventricular foramen morphology', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(555996, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0002152', 'abnormal brain morphology', 0.5, 6.213399309526074, 1.762583233428435, 'UPHENO:0076805', 'abnormal brain morphology'),
(555997, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0013306', 'abnormal tela choroidea morphology', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(555998, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0014276', 'lobar holoprosencephaly', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(555999, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0010744', 'abnormal cervical flexure morphology', 0.45161290322580644, 6.213399309526074, 1.675127249219083, 'UPHENO:0076805', 'abnormal brain morphology'),
(556000, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0002878', 'abnormal corticospinal tract morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(556001, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0008025', 'brain vacuoles', 0.4666666666666667, 6.213399309526074, 1.7028171788085475, 'UPHENO:0076805', 'abnormal brain morphology'),
(556002, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000844', 'abnormal pontine flexure morphology', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(556003, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0014066', 'Rosenthal fibers', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(556004, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0008857', 'myelencephalic blebs', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(556005, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0008493', 'alpha-synuclein inclusion body', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(556006, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000913', 'abnormal brain development', 0.4666666666666667, 6.213399309526074, 1.7028171788085475, 'UPHENO:0076805', 'abnormal brain morphology'),
(556007, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0006007', 'abnormal basal ganglion morphology', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(556008, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0020452', 'abnormal axon radial sorting', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(556009, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0002200', 'abnormal brain ventricular system morphology', 0.4666666666666667, 6.213399309526074, 1.7028171788085475, 'UPHENO:0076805', 'abnormal brain morphology'),
(556010, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0012267', 'abnormal red nucleus morphology', 0.42857142857142855, 9.637520916954793, 2.0323302160983436, 'UPHENO:0076795', 'abnormal midbrain morphology'),
(556011, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000955', 'abnormal spinal cord morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(556012, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000830', 'abnormal diencephalon morphology', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(556013, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0004996', 'abnormal CNS synapse formation', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(556014, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0003214', 'neurofibrillary tangles', 0.45161290322580644, 6.213399309526074, 1.675127249219083, 'UPHENO:0076805', 'abnormal brain morphology'),
(556015, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0008027', 'abnormal spinal cord white matter morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(556016, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000787', 'abnormal telencephalon morphology', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(556017, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0001889', 'delayed brain development', 0.45161290322580644, 6.213399309526074, 1.675127249219083, 'UPHENO:0076805', 'abnormal brain morphology'),
(556018, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0009685', 'abnormal spinal cord motor column morphology', 0.41935483870967744, 5.838687225017717, 1.5647625185706484, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(556019, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0003632', 'abnormal nervous system morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(556020, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000914', 'exencephaly', 0.45161290322580644, 6.213399309526074, 1.675127249219083, 'UPHENO:0076805', 'abnormal brain morphology'),
(556021, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0004280', 'abnormal oculomotor nucleus morphology', 0.42857142857142855, 9.637520916954793, 2.0323302160983436, 'UPHENO:0076795', 'abnormal midbrain morphology'),
(556022, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0002184', 'abnormal innervation', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(556023, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0013935', 'basal brain tissue herniation', 0.4827586206896552, 6.213399309526074, 1.7319272734329416, 'UPHENO:0076805', 'abnormal brain morphology'),
(556024, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0013934', 'supratentorial ventricles enlargement', 0.42424242424242425, 6.213399309526074, 1.6235724763186725, 'UPHENO:0076805', 'abnormal brain morphology'),
(556025, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0000778', 'abnormal nervous system tract morphology', 0.4482758620689655, 5.838687225017717, 1.6178203080521252, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(556026, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0004166', 'abnormal limbic system morphology', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(556027, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0014061', 'ethmocephaly', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(556028, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0014277', 'alobar holoprosencephaly', 0.4375, 6.213399309526074, 1.6487456437903505, 'UPHENO:0076805', 'abnormal brain morphology'),
(556029, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0012711', 'diplomyelia', 0.43333333333333335, 5.838687225017717, 1.590628114144748, 'UPHENO:0076791', 'abnormal central nervous system morphology'),
(556030, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0009637', 'abnormal pretectal region morphology', 0.45454545454545453, 9.637520916954793, 2.093010111272409, 'UPHENO:0076795', 'abnormal midbrain morphology'),
(556031, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0010892', 'increased oligodendrocyte progenitor number', 0.45161290322580644, 6.213399309526074, 1.675127249219083, 'UPHENO:0076805', 'abnormal brain morphology'),
(556032, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0002199', 'abnormal brain commissure morphology', 0.4117647058823529, 6.213399309526074, 1.5995182209704955, 'UPHENO:0076805', 'abnormal brain morphology'),
(556033, 'HP:0034259', 'Hypoplasia of the midbrain', 'MP:0009638', 'abnormal pretectal nuclei morphology', 0.42857142857142855, 9.637520916954793, 2.0323302160983436, 'UPHENO:0076795', 'abnormal midbrain morphology'),
(556034, 'HP:0030410', 'Sebaceous gland carcinoma', 'MP:0001211', 'wrinkled skin', 0.4166666666666667, 6.904974582545727, 1.6961936041405727, 'UPHENO:0003811', 'abnormal skin of body'),
(556035, 'HP:0030410', 'Sebaceous gland carcinoma', 'MP:0009932', 'skin fibrosis', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(556036, 'HP:0030410', 'Sebaceous gland carcinoma', 'MP:0001197', 'oily skin', 0.40540540540540543, 6.904974582545727, 1.6731150647672055, 'UPHENO:0003811', 'abnormal skin of body'),
(556037, 'HP:0030410', 'Sebaceous gland carcinoma', 'MP:0003196', 'calcified skin', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(556038, 'HP:0030410', 'Sebaceous gland carcinoma', 'MP:0000367', 'abnormal coat/ hair morphology', 0.42424242424242425, 8.50911518495075, 1.89998096154186, 'UPHENO:0086842', 'abnormal integumentary adnexa morphology'),
(556039, 'HP:0025409', 'Abnormal spleen physiology', 'MP:0008737', 'abnormal spleen physiology', 0.43902439024390244, 14.607147267911275, 2.5323692310754433, 'UPHENO:0002432', 'abnormality of spleen physiology'),
(556040, 'HP:0030882', 'Coronary artery aneurysm', 'MP:0010476', 'coronary fistula', 0.4222222222222222, 12.607147267911277, 2.3071666032907805, 'UPHENO:0076721', 'abnormal coronary artery morphology'),
(556041, 'HP:0030882', 'Coronary artery aneurysm', 'MP:0011656', 'coronary arterio-venous fistula', 0.41304347826086957, 12.607147267911277, 2.2819509106212372, 'UPHENO:0076721', 'abnormal coronary artery morphology'),
(556042, 'HP:0030882', 'Coronary artery aneurysm', 'MP:0006133', 'calcified artery', 0.4090909090909091, 8.259895016664046, 1.838218692474474, 'UPHENO:0086797', 'abnormal artery morphology'),
(556043, 'HP:0030882', 'Coronary artery aneurysm', 'MP:0011657', 'coronary-cameral fistula', 0.40425531914893614, 12.607147267911277, 2.257544316806895, 'UPHENO:0076721', 'abnormal coronary artery morphology'),
(556044, 'HP:0030882', 'Coronary artery aneurysm', 'MP:0004111', 'abnormal coronary artery morphology', 0.4318181818181818, 12.607147267911277, 2.3332371099276443, 'UPHENO:0076721', 'abnormal coronary artery morphology'),
(556045, 'HP:0030882', 'Coronary artery aneurysm', 'MP:0010477', 'coronary artery aneurysm', 0.41304347826086957, 12.607147267911277, 2.2819509106212372, 'UPHENO:0076721', 'abnormal coronary artery morphology'),
(556046, 'HP:0005599', 'Hypopigmentation of hair', 'MP:0011277', 'decreased tail pigmentation', 0.46153846153846156, 12.607147267911277, 2.412194717351937, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(556047, 'HP:0005599', 'Hypopigmentation of hair', 'MP:0030930', 'decreased digit pigmentation', 0.4225352112676056, 12.607147267911277, 2.3080215844590164, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(556048, 'HP:0005599', 'Hypopigmentation of hair', 'MP:0005408', 'hypopigmentation', 0.4423076923076923, 12.285219173023913, 2.331061333795064, 'UPHENO:0077877', 'decreased pigmentation in multicellular organism'),
(556049, 'HP:0005599', 'Hypopigmentation of hair', 'MP:0011627', 'decreased skin pigmentation', 0.5172413793103449, 12.607147267911277, 2.553612782319018, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(556050, 'HP:0005599', 'Hypopigmentation of hair', 'MP:0020221', 'reduced foot pad pigmentation', 0.4177215189873418, 12.607147267911277, 2.2948369673789495, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(556051, 'HP:0005599', 'Hypopigmentation of hair', 'MP:0011568', 'decreased foot pigmentation', 0.47619047619047616, 12.607147267911277, 2.4501843728401607, 'UPHENO:0077885', 'decreased pigmentation in skin of body'),
(556052, 'HP:0002461', 'Cerebellar dentate nucleus calcification', 'MP:0012488', 'decreased cerebellum dentate nucleus size', 0.40350877192982454, 14.732678149995134, 2.438188849851852, 'UPHENO:0081580', 'abnormal dentate nucleus morphology'),
(556053, 'HP:0002461', 'Cerebellar dentate nucleus calcification', 'MP:0012487', 'increased cerebellum dentate nucleus size', 0.40350877192982454, 14.732678149995134, 2.438188849851852, 'UPHENO:0081580', 'abnormal dentate nucleus morphology'),
(556054, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556055, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556056, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556057, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556058, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556059, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556060, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556061, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556062, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556063, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556064, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556065, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556066, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556067, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556068, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556069, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556070, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556071, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556072, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556073, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556074, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556075, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556076, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556077, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556078, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556079, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556080, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005190', 'osteomyelitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556081, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556082, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556083, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556084, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556085, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556086, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556087, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556088, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556089, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003777', 'lip inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556090, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556091, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556092, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556093, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556094, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556095, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556096, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556097, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031066', 'cytokine storm', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556098, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556099, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556100, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0000751', 'myopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556101, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556102, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556103, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556104, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556105, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556106, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556107, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556108, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556109, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556110, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556111, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556112, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556113, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556114, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556115, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556116, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556117, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556118, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556119, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556120, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556121, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556122, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556123, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556124, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556125, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556126, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556127, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556128, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556129, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0011764', 'ureteritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556130, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556131, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556132, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556133, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556134, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556135, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556136, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556137, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556138, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556139, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556140, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556141, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556142, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556143, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556144, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0012565', 'perivasculitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556145, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556146, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556147, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556148, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556149, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556150, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556151, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556152, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556153, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556154, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556155, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0013942', 'enthesitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556156, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556157, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556158, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556159, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556160, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556161, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556162, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556163, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556164, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556165, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556166, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556167, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003767', 'palate inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556168, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556169, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556170, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556171, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556172, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556173, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001873', 'stomach inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556174, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556175, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556176, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556177, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556178, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556179, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556180, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556181, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556182, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556183, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004947', 'skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556184, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556185, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556186, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556187, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556188, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556189, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556190, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556191, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556192, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556193, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556194, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556195, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556196, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556197, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556198, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556199, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556200, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556201, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556202, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556203, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556204, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556205, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556206, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556207, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556208, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556209, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556210, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003746', 'stomatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556211, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556212, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556213, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556214, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556215, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001844', 'autoimmune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556216, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556217, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556218, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556219, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556220, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556221, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556222, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556223, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556224, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556225, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556226, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556227, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556228, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556229, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556230, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556231, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556232, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556233, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556234, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556235, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556236, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556237, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556238, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556239, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556240, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556241, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556242, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556243, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556244, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556245, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556246, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556247, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556248, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556249, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556250, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556251, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556252, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556253, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556254, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556255, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556256, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556257, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556258, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556259, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556260, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556261, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556262, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556263, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556264, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556265, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556266, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556267, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556268, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556269, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556270, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556271, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556272, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556273, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556274, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556275, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556276, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556277, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556278, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556279, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556280, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556281, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031053', 'pleuritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556282, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556283, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005044', 'sepsis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556284, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031302', 'syncope', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556285, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556286, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556287, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556288, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556289, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556290, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556291, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556292, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556293, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556294, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556295, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556296, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556297, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556298, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556299, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556300, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556301, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556302, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556303, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556304, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556305, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556306, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556307, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556308, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556309, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556310, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001847', 'brain inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556311, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556312, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556313, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556314, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556315, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556316, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556317, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556318, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556319, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556320, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556321, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556322, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556323, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556324, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556325, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556326, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556327, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556328, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556329, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556330, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556331, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556332, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556333, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556334, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556335, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556336, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556337, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556338, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556339, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556340, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556341, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556342, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556343, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556344, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556345, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556346, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556347, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556348, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556349, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556350, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556351, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556352, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556353, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556354, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556355, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556356, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556357, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556358, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556359, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556360, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556361, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556362, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0030129', 'tongue inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556363, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556364, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031095', 'pharyngitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556365, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556366, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556367, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0011763', 'urethritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556368, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556369, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556370, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556371, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556372, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556373, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556374, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556375, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556376, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556377, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556378, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556379, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556380, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556381, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556382, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556383, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556384, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556385, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556386, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556387, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556388, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556389, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556390, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556391, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556392, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556393, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556394, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556395, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556396, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556397, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556398, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556399, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556400, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556401, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004510', 'myositis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556402, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556403, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556404, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556405, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556406, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556407, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556408, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556409, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556410, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556411, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556412, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556413, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556414, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556415, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556416, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556417, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556418, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556419, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556420, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556421, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0013136', 'genital discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556422, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556423, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556424, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556425, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556426, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556427, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556428, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556429, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556430, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556431, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556432, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0001861', 'lung inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556433, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556434, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(556435, 'HP:0033576', 'Anti-H2B antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556436, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003464', 'abnormal single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556437, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.4411764705882353, 7.291997705654976, 1.793615848312668, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556438, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003633', 'abnormal nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556439, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556440, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003474', 'abnormal summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556441, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0011994', 'increased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556442, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556443, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556444, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556445, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003880', 'abnormal central pattern generator function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556446, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0013806', 'encephalopathy', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556447, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556448, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4166666666666667, 7.291997705654976, 1.7430812882238855, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556449, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003463', 'abnormal single cell response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556450, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556451, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556452, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003470', 'abnormal summary potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556453, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0005403', 'abnormal nerve conduction', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556454, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.4411764705882353, 7.291997705654976, 1.793615848312668, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556455, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556456, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0002064', 'seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556457, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0004994', 'abnormal brain wave pattern', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556458, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0002578', 'impaired ability to fire action potentials', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556459, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556460, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556461, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0004513', 'avnosmia', 0.42857142857142855, 7.291997705654976, 1.7678070804960966, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556462, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4166666666666667, 7.291997705654976, 1.7430812882238855, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556463, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003467', 'abnormal single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556464, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0006080', 'brain ischemia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556465, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556466, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556467, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556468, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556469, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556470, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556471, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556472, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0021015', 'increased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556473, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0012006', 'abnormal hippocampus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556474, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556475, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003477', 'abnormal nerve fiber response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556476, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556477, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003889', 'enhanced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556478, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0002634', 'abnormal sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556479, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556480, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556481, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0008814', 'decreased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556482, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0005402', 'abnormal action potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556483, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556484, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0003471', 'abnormal summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556485, 'HP:0007230', 'Decreased distal sensory nerve action potential', 'MP:0002635', 'reduced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(556486, 'HP:0003191', 'Cleft ala nasi', 'MP:0030045', 'abnormal forehead shape', 0.41509433962264153, 6.5236679405794336, 1.6455812455519228, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(556487, 'HP:0003191', 'Cleft ala nasi', 'MP:0011495', 'abnormal head shape', 0.40816326530612246, 6.5236679405794336, 1.6317847923055813, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(556488, 'HP:0003191', 'Cleft ala nasi', 'MP:0030074', 'coarse facial features', 0.4230769230769231, 6.5236679405794336, 1.6613287933085112, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(556489, 'HP:0003191', 'Cleft ala nasi', 'MP:0030116', 'bifid nasal tip', 0.4406779661016949, 12.002285209752415, 2.29981360870966, 'UPHENO:0088168', 'abnormal external nose morphology'),
(556490, 'HP:0003191', 'Cleft ala nasi', 'MP:0030071', 'abnormal face shape', 0.43137254901960786, 6.5236679405794336, 1.677537262920036, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(556491, 'HP:0003191', 'Cleft ala nasi', 'MP:0030117', 'bifid nose', 0.45614035087719296, 11.203425081860265, 2.260604841157801, 'UPHENO:0041202', 'concave anatomical entity'),
(556492, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0020404', 'prolinuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556493, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0011765', 'oroticaciduria', 0.5079365079365079, 10.47786425096631, 2.3069654913475843, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556494, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0030613', 'dicarboxylic aciduria', 0.5862068965517241, 12.732678149995134, 2.732029235403713, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(556495, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0011517', 'hyperoxaluria', 0.5230769230769231, 12.732678149995134, 2.580730537895854, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(556496, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0020406', 'hyperthreoninuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556497, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0030617', 'hyperglutaminuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556498, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0011516', 'aspartylglucosaminuria', 0.463768115942029, 10.47786425096631, 2.204381855025799, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556499, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0020403', 'lysinuria', 0.4050632911392405, 10.47786425096631, 2.060145183623379, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556500, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0030618', 'tryptophanuria', 0.43243243243243246, 10.47786425096631, 2.128607132549872, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556501, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0030620', 'valinuria', 0.4050632911392405, 10.47786425096631, 2.060145183623379, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556502, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0002931', 'glutaricadicuria', 0.5, 12.732678149995134, 2.5231605329422795, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(556503, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0030612', 'organic aciduria', 0.42105263157894735, 10.430558536187952, 2.0956655554978685, 'UPHENO:0068144', 'increased level of organic acid in urine'),
(556504, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0003311', 'aminoaciduria', 0.47058823529411764, 10.47786425096631, 2.2205313885449938, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556505, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0020405', 'taurinuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556506, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0030689', 'cystathioninuria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556507, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0020400', 'cystinuria', 0.43243243243243246, 10.47786425096631, 2.128607132549872, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556508, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0030682', 'hydroxyprolinuria', 0.4050632911392405, 10.47786425096631, 2.060145183623379, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556509, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0030734', 'increased urine gamma-aminobutyric acid level', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556510, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0030615', 'ethylmalonic aciduria', 0.5, 12.732678149995134, 2.5231605329422795, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(556511, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0030614', 'methylmalonic aciduria', 0.5074626865671642, 12.732678149995134, 2.5419203491045037, 'UPHENO:0068078', 'increased level of dicarboxylic acid in urine'),
(556512, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0020401', 'argininuria', 0.4155844155844156, 10.47786425096631, 2.086728801572134, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556513, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0011654', 'histidinuria', 0.43243243243243246, 10.47786425096631, 2.128607132549872, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556514, 'HP:0003215', 'Dicarboxylic aciduria', 'MP:0020402', 'ornithinuria', 0.41025641025641024, 10.47786425096631, 2.0733091845538643, 'UPHENO:0068491', 'increased level of carboxylic acid in urine'),
(556515, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011919', 'abnormal R wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556516, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011952', 'decreased cardiac stroke volume', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556517, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556518, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011938', 'prolonged PP interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556519, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011936', 'abnormal PP interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556520, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556521, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004877', 'abnormal systemic vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556522, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003039', 'increased time of peak ischemic contracture', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556523, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011954', 'shortened PQ interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556524, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0000304', 'abnormal cardiac stroke volume', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556525, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556526, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0031302', 'syncope', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556527, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556528, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0001627', 'abnormal cardiac output', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556529, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020161', 'increased vascular endothelial cell proliferation', 0.4146341463414634, 11.410750055107773, 2.175152088525172, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556530, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010560', 'intraventricular block', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556531, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0001914', 'hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556532, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0001634', 'internal hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556533, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010519', 'atrioventricular block', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556534, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020320', 'abnormal vascular endothelial cell apoptosis', 0.425, 11.410750055107773, 2.2021736474267426, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556535, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004485', 'increased response of heart to induced stress', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556536, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010514', 'fragmented QRS complex', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556537, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556538, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003882', 'abnormal pulse pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556539, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004010', 'increased diastolic filling velocity', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556540, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011927', 'abnormal cardiac valve flow', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556541, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0009275', 'bruising', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556542, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004176', 'ear telangiectases', 0.425, 11.410750055107773, 2.2021736474267426, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556543, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010504', 'abnormal RR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556544, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556545, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0005333', 'decreased heart rate', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556546, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0031128', 'cardiovascular shunt', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556547, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556548, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010511', 'shortened PR interval', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556549, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0013135', 'poor circulation in tail', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556550, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0031170', 'abnormal vasculature physiology', 0.5, 11.346619717688057, 2.381871083590384, 'UPHENO:0002410', 'abnormality of vessel physiology'),
(556551, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003071', 'decreased vascular permeability', 0.4358974358974359, 11.410750055107773, 2.2302279459032888, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556552, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020318', 'increased vascular endothelial cell adhesion', 0.425, 11.410750055107773, 2.2021736474267426, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556553, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0009384', 'cardiac valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556554, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020319', 'decreased vascular endothelial cell adhesion', 0.425, 11.410750055107773, 2.2021736474267426, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556555, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0002842', 'increased systemic arterial blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556556, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556557, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556558, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556559, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556560, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0031129', 'left-to-right shunt', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556561, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006048', 'pulmonary valve regurgitation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556562, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003394', 'increased cardiac output', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556563, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0001598', 'abnormal blood viscosity', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556564, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0005167', 'abnormal blood-brain barrier function', 0.4594594594594595, 11.410750055107773, 2.289711128580812, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556565, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004177', 'tail telangiectases', 0.425, 11.410750055107773, 2.2021736474267426, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556566, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004217', 'salt-sensitive hypertension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556567, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004484', 'abnormal response of heart to induced stress', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556568, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010140', 'phlebitis', 0.425, 11.410750055107773, 2.2021736474267426, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556569, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004216', 'salt-resistant hypertension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556570, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556571, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011953', 'prolonged PQ interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556572, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556573, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004156', 'abnormal QT variability', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556574, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010505', 'abnormal T wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556575, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011930', 'abnormal tricuspid valve flow', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556576, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010520', 'sinoatrial block', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556577, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003929', 'decreased heart rate variability', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556578, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010393', 'shortened QRS complex duration', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556579, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010631', 'increased Q wave amplitude', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556580, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556581, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556582, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004486', 'decreased response of heart to induced stress', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556583, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556584, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003070', 'increased vascular permeability', 0.4358974358974359, 11.410750055107773, 2.2302279459032888, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556585, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003025', 'increased vasoconstriction', 0.425, 11.410750055107773, 2.2021736474267426, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556586, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003901', 'abnormal PR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556587, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556588, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010636', 'bundle branch block', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556589, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006045', 'mitral valve regurgitation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556590, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556591, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006044', 'tricuspid valve regurgitation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556592, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004879', 'decreased systemic vascular resistance', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556593, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010571', 'shortened ST segment', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556594, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004009', 'abnormal diastolic filling velocity', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556595, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556596, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010559', 'heart block', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556597, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0005590', 'increased vasodilation', 0.4358974358974359, 11.410750055107773, 2.2302279459032888, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556598, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004003', 'abnormal vascular endothelial cell physiology', 0.4594594594594595, 11.410750055107773, 2.289711128580812, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556599, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0005532', 'abnormal vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556600, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0031130', 'right-to-left shunt', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556601, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006088', 'abnormal blood-cerebrospinal fluid barrier function', 0.4594594594594595, 11.410750055107773, 2.289711128580812, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556602, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0005435', 'hemoperitoneum', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556603, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010570', 'prolonged ST segment', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556604, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020097', 'low mean heart rate adaptation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556605, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003233', 'prolonged QT interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556606, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0002626', 'increased heart rate', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556607, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011918', 'abnormal PQ interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556608, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0031384', 'impaired blood-brain barrier function', 0.4146341463414634, 11.410750055107773, 2.175152088525172, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556609, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003900', 'shortened QT interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556610, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0001863', 'blood vessel inflammation', 0.4358974358974359, 11.410750055107773, 2.2302279459032888, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556611, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556612, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0001596', 'hypotension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556613, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556614, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003034', 'increased pulmonary vascular resistance', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556615, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010554', 'shortened HV interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556616, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.53125, 11.410750055107773, 2.4621049869524256, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556617, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556618, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556619, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006114', 'cardiac murmur', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556620, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0000249', 'abnormal blood vessel physiology', 0.5483870967741935, 11.410750055107773, 2.5015011682460835, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556621, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010394', 'decreased QRS amplitude', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556622, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004072', 'abnormal frontal plane axis', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556623, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556624, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556625, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003928', 'increased heart rate variability', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556626, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006047', 'aortic valve regurgitation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556627, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004085', 'abnormal heartbeat', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556628, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0009698', 'heart hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556629, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020146', 'abnormal vascular endothelial cell proliferation', 0.4358974358974359, 11.410750055107773, 2.2302279459032888, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556630, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003823', 'increased left ventricle developed pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556631, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0005595', 'abnormal vascular smooth muscle physiology', 0.4594594594594595, 11.410750055107773, 2.289711128580812, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556632, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004011', 'decreased diastolic filling velocity', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556633, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011928', 'abnormal mitral valve flow', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556634, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0001613', 'abnormal vasodilation', 0.4473684210526316, 11.410750055107773, 2.2593824897922428, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556635, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0008950', 'ventricular tachycardia', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556636, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010634', 'increased QRS amplitude', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556637, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556638, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006049', 'semilunar valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556639, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003899', 'abnormal QT interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556640, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006046', 'atrioventricular valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556641, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006138', 'congestive heart failure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556642, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010552', 'abnormal HV interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556643, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010515', 'abnormal Q wave', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556644, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556645, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003820', 'increased left ventricle systolic pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556646, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0008776', 'increased right ventricle peak pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556647, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0001636', 'irregular heartbeat', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556648, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556649, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0009732', 'ventricular premature beat', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556650, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003393', 'decreased cardiac output', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556651, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020096', 'high mean heart rate adaptation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556652, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020321', 'increased vascular endothelial cell apoptosis', 0.4146341463414634, 11.410750055107773, 2.175152088525172, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556653, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010513', 'abnormal ventricular activation time', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556654, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556655, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003438', 'abnormal carotid body physiology', 0.5151515151515151, 11.410750055107773, 2.424513390332997, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556656, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020322', 'decreased vascular endothelial cell apoptosis', 0.4146341463414634, 11.410750055107773, 2.175152088525172, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556657, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556658, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004122', 'abnormal sinus arrhythmia', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556659, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0001864', 'vascular inflammation', 0.4166666666666667, 11.346619717688057, 2.174340869252877, 'UPHENO:0002410', 'abnormality of vessel physiology'),
(556660, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020317', 'abnormal vascular endothelial cell adhesion', 0.4358974358974359, 11.410750055107773, 2.2302279459032888, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556661, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003026', 'decreased vasoconstriction', 0.40476190476190477, 11.410750055107773, 2.1491014231690957, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556662, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0013134', 'poor circulation in autopods', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556663, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006265', 'increased pulse pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556664, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0031385', 'enhanced blood-brain barrier function', 0.4473684210526316, 11.410750055107773, 2.2593824897922428, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556665, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0012045', 'increased susceptibility to hypertension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556666, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010756', 'decreased right ventricle peak pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556667, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003898', 'abnormal QRS complex', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556668, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0002128', 'abnormal blood circulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556669, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0001619', 'abnormal vascular permeability', 0.4473684210526316, 11.410750055107773, 2.2593824897922428, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556670, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010758', 'increased right ventricle systolic pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556671, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011931', 'abnormal pulmonary valve flow', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556672, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004878', 'increased systemic vascular resistance', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556673, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010695', 'abnormal blood pressure regulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556674, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006266', 'decreased pulse pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556675, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003711', 'pathological neovascularization', 0.40476190476190477, 11.410750055107773, 2.1491014231690957, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556676, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011926', 'abnormal heart valve physiology', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556677, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011937', 'shortened PP interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556678, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556679, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010139', 'aortitis', 0.4146341463414634, 11.410750055107773, 2.175152088525172, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556680, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020316', 'decreased vascular endothelial cell proliferation', 0.4146341463414634, 11.410750055107773, 2.175152088525172, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556681, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010509', 'decreased P wave amplitude', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556682, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0008817', 'hematoma', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556683, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556684, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556685, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0005591', 'decreased vasodilation', 0.4358974358974359, 11.410750055107773, 2.2302279459032888, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556686, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0012046', 'decreased susceptibility to hypertension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556687, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0020842', 'abnormal supporting cell of carotid body physiology', 0.4358974358974359, 11.410750055107773, 2.2302279459032888, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556688, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010637', 'sinus bradycardia', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556689, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004175', 'telangiectases', 0.4358974358974359, 11.410750055107773, 2.2302279459032888, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556690, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004178', 'neck telangiectases', 0.425, 11.410750055107773, 2.2021736474267426, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556691, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0001633', 'poor circulation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556692, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003824', 'decreased left ventricle developed pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556693, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0000343', 'abnormal response to cardiac infarction', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556694, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0031192', 'coronary artery spasm', 0.53125, 11.410750055107773, 2.4621049869524256, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556695, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010138', 'arteritis', 0.425, 11.410750055107773, 2.2021736474267426, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556696, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556697, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010510', 'absent P wave', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556698, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556699, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0000231', 'hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556700, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556701, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003897', 'abnormal ST segment', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556702, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556703, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003547', 'abnormal pulmonary pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556704, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010512', 'absent PR interval', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556705, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0001629', 'abnormal heart rate', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556706, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556707, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004999', 'abnormal blood-inner ear barrier function', 0.425, 11.410750055107773, 2.2021736474267426, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556708, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556709, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011920', 'abnormal S wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556710, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010516', 'absent Q wave', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556711, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0004070', 'abnormal P wave', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556712, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0000250', 'abnormal vasoconstriction', 0.4358974358974359, 11.410750055107773, 2.2302279459032888, 'UPHENO:0002343', 'abnormality of blood vessel physiology'),
(556713, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556714, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011929', 'abnormal aortic valve flow', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556715, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0005330', 'cardiomyopathy', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556716, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0011951', 'increased cardiac stroke volume', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556717, 'HP:0025018', 'Abnormal capillary physiology', 'MP:0010553', 'prolonged HV interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556718, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556719, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010505', 'abnormal T wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556720, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006046', 'atrioventricular valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556721, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031130', 'right-to-left shunt', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556722, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556723, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556724, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011954', 'shortened PQ interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556725, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003928', 'increased heart rate variability', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556726, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011929', 'abnormal aortic valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556727, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0008776', 'increased right ventricle peak pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556728, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031152', 'subcutaneous hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556729, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0009384', 'cardiac valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556730, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001634', 'internal hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556731, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004072', 'abnormal frontal plane axis', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556732, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001598', 'abnormal blood viscosity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556733, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556734, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556735, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010553', 'prolonged HV interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556736, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031385', 'enhanced blood-brain barrier function', 0.40540540540540543, 8.605269980670606, 1.8677855779335946, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556737, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556738, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0000465', 'gastrointestinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556739, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010636', 'bundle branch block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556740, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003820', 'increased left ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556741, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001983', 'abnormal olfactory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556742, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556743, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556744, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0008271', 'abnormal bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556745, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556746, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556747, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0020419', 'decreased cardiac muscle relaxation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556748, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556749, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556750, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010756', 'decreased right ventricle peak pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556751, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556752, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003233', 'prolonged QT interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556753, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003823', 'increased left ventricle developed pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556754, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001663', 'abnormal digestive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556755, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031128', 'cardiovascular shunt', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556756, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556757, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0005671', 'abnormal response to transplant', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556758, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0013134', 'poor circulation in autopods', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556759, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556760, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0009697', 'abnormal copulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556761, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003899', 'abnormal QT interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556762, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001542', 'abnormal bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556763, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556764, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002626', 'increased heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556765, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556766, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004156', 'abnormal QT variability', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556767, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556768, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556769, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556770, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556771, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001835', 'abnormal antigen presentation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556772, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556773, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556774, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556775, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556776, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003039', 'increased time of peak ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556777, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556778, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004211', 'abnormal sour taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556779, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556780, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556781, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0030988', 'dysosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556782, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010515', 'abnormal Q wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556783, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556784, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0020000', 'abnormal response to antigen', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556785, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556786, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011930', 'abnormal tricuspid valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556787, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011953', 'prolonged PQ interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556788, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002952', 'ventricular cardiomyopathy', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556789, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031302', 'syncope', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556790, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011931', 'abnormal pulmonary valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556791, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006265', 'increased pulse pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556792, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556793, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556794, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001619', 'abnormal vascular permeability', 0.40540540540540543, 8.605269980670606, 1.8677855779335946, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556795, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556796, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556797, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001790', 'abnormal immune system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556798, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004086', 'absent heartbeat', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556799, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011936', 'abnormal PP interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556800, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556801, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001845', 'abnormal inflammatory response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556802, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556803, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010514', 'fragmented QRS complex', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556804, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006088', 'abnormal blood-cerebrospinal fluid barrier function', 0.4166666666666667, 8.605269980670606, 1.8935493546809792, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556805, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031192', 'coronary artery spasm', 0.4838709677419355, 8.605269980670606, 2.0405490225004916, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556806, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556807, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556808, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004013', 'decreased pulmonary artery pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556809, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556810, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011951', 'increased cardiac stroke volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556811, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031089', 'sneezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556812, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0013135', 'poor circulation in tail', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556813, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010506', 'prolonged RR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556814, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556815, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556816, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0009732', 'ventricular premature beat', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556817, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006048', 'pulmonary valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556818, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006044', 'tricuspid valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556819, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006266', 'decreased pulse pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556820, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556821, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0000304', 'abnormal cardiac stroke volume', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556822, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003929', 'decreased heart rate variability', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556823, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.4838709677419355, 8.605269980670606, 2.0405490225004916, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556824, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556825, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011928', 'abnormal mitral valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556826, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004003', 'abnormal vascular endothelial cell physiology', 0.4166666666666667, 8.605269980670606, 1.8935493546809792, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556827, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0008817', 'hematoma', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556828, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011918', 'abnormal PQ interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556829, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556830, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002998', 'abnormal bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556831, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001596', 'hypotension', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556832, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004145', 'abnormal muscle electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556833, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001914', 'hemorrhage', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556834, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556835, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556836, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002128', 'abnormal blood circulation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556837, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556838, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556839, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556840, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003824', 'decreased left ventricle developed pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556841, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556842, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003438', 'abnormal carotid body physiology', 0.46875, 8.605269980670606, 2.008412383809497, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556843, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556844, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556845, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556846, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003549', 'pulmonary hypotension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556847, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0008950', 'ventricular tachycardia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556848, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010559', 'heart block', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556849, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0009275', 'bruising', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556850, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004877', 'abnormal systemic vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556851, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010509', 'decreased P wave amplitude', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556852, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010637', 'sinus bradycardia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556853, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003633', 'abnormal nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556854, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010516', 'absent Q wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556855, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556856, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004012', 'increased pulmonary artery pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556857, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010520', 'sinoatrial block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556858, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010511', 'shortened PR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556859, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010519', 'atrioventricular block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556860, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556861, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556862, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011938', 'prolonged PP interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556863, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556864, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556865, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556866, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004070', 'abnormal P wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556867, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006054', 'spinal hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556868, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003548', 'pulmonary hypertension', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556869, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556870, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003901', 'abnormal PR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556871, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006111', 'abnormal coronary circulation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556872, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010552', 'abnormal HV interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556873, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556874, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556875, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003034', 'increased pulmonary vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556876, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0005333', 'decreased heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556877, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031098', 'abnormal sputum production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556878, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004036', 'abnormal muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556879, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556880, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556881, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556882, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002420', 'abnormal adaptive immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556883, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003547', 'abnormal pulmonary pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556884, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556885, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0009698', 'heart hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556886, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556887, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556888, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556889, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556890, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011952', 'decreased cardiac stroke volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556891, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0005167', 'abnormal blood-brain barrier function', 0.4166666666666667, 8.605269980670606, 1.8935493546809792, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556892, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010570', 'prolonged ST segment', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556893, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001629', 'abnormal heart rate', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556894, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031129', 'left-to-right shunt', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556895, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556896, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003186', 'abnormal redox activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556897, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556898, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004484', 'abnormal response of heart to induced stress', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556899, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010554', 'shortened HV interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556900, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556901, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556902, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006080', 'brain ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556903, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004071', 'prolonged P wave', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556904, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556905, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004245', 'genital hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556906, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0012045', 'increased susceptibility to hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556907, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001943', 'abnormal respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556908, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003868', 'abnormal feces composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556909, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0000249', 'abnormal blood vessel physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556910, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031136', 'muscle hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556911, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556912, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004879', 'decreased systemic vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556913, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003897', 'abnormal ST segment', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556914, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002842', 'increased systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556915, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556916, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556917, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010512', 'absent PR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556918, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003077', 'abnormal cell cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556919, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556920, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0020345', 'abnormal myocardial fiber currents', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556921, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010504', 'abnormal RR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556922, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556923, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556924, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0005330', 'cardiomyopathy', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556925, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556926, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0005435', 'hemoperitoneum', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556927, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001627', 'abnormal cardiac output', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556928, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556929, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556930, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003037', 'increased myocardial infarct size', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556931, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556932, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556933, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003393', 'decreased cardiac output', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556934, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002723', 'abnormal immune serum protein physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556935, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003900', 'shortened QT interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556936, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556937, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001599', 'abnormal blood volume', 0.46875, 8.605269980670606, 2.008412383809497, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556938, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0012382', 'abnormal blood cell physiology', 0.4642857142857143, 5.816527256141925, 1.6433290941805234, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(556939, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010513', 'abnormal ventricular activation time', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556940, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556941, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010631', 'increased Q wave amplitude', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556942, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0009562', 'abnormal odor adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556943, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556944, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011920', 'abnormal S wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556945, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010560', 'intraventricular block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556946, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010510', 'absent P wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556947, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556948, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0005000', 'abnormal immune tolerance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556949, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001633', 'poor circulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556950, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556951, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004122', 'abnormal sinus arrhythmia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556952, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011937', 'shortened PP interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556953, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010571', 'shortened ST segment', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556954, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004085', 'abnormal heartbeat', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556955, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0011919', 'abnormal R wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556956, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0020418', 'increased cardiac muscle relaxation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556957, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556958, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0000343', 'abnormal response to cardiac infarction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556959, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556960, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556961, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0013127', 'epistaxis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556962, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004217', 'salt-sensitive hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556963, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0002421', 'abnormal cell-mediated immunity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556964, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0010393', 'shortened QRS complex duration', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556965, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006049', 'semilunar valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556966, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556967, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556968, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556969, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(556970, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004010', 'increased diastolic filling velocity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556971, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0004486', 'decreased response of heart to induced stress', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556972, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0005532', 'abnormal vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556973, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556974, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0000233', 'abnormal blood flow velocity', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556975, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003896', 'prolonged PR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556976, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0005599', 'increased cardiac muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556977, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0001613', 'abnormal vasodilation', 0.40540540540540543, 8.605269980670606, 1.8677855779335946, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(556978, 'HP:0030972', 'Abnormal systemic blood pressure', 'MP:0003038', 'decreased myocardial infarct size', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
